Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ranibizumab vs PDT for Presumed Ocular Histoplasmosis

NCT00546936 is registered in ClinicalTrials.gov with Barnes Retina Institute as lead sponsor.

NCT NCT00546936
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00546936 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ranibizumab vs PDT for Presumed Ocular Histoplasmosis
Lead sponsor
Barnes Retina Institute
Phase
Phase 2
Overall status
Unknown status
Start date
October 31, 2007
Completion date
April 30, 2010
Enrollment
30 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

presumed ocular histoplasmosis (pohs)